Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14765: Variant p.His623Tyr

Signal transducer and activator of transcription 4
Gene: STAT4
Feedback?
Variant information Variant position: help 623 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Histidine (H) to Tyrosine (Y) at position 623 (H623Y, p.His623Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (H) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In DPMC; likely pathogenic; increased function in receptor signaling pathway via JAK-STAT. Any additional useful information about the variant.


Sequence information Variant position: help 623 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 748 The length of the canonical sequence.
Location on the sequence: help HLGGITFTWVDHSESGEVRF H SVEPYNKGRLSALPFADILR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         HLGGITFTWVDHSESGEVRFHSVEPYNKGRLSALPFADILR

Mouse                         HLGGITFTWVDQSENGEVRFHSVEPYNKGRLSALAFADILR
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 748 Signal transducer and activator of transcription 4
Domain 569 – 664 SH2



Literature citations
Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
Baghdassarian H.; Blackstone S.A.; Clay O.S.; Philips R.; Matthiasardottir B.; Nehrebecky M.; Hua V.K.; McVicar R.; Liu Y.; Tucker S.M.; Randazzo D.; Deuitch N.; Rosenzweig S.; Mark A.; Sasik R.; Fisch K.M.; Pimpale Chavan P.; Eren E.; Watts N.R.; Ma C.A.; Gadina M.; Schwartz D.M.; Sanyal A.; Werner G.; Murdock D.R.; Horita N.; Chowdhury S.; Dimmock D.; Jepsen K.; Remmers E.F.; Goldbach-Mansky R.; Gahl W.A.; O'Shea J.J.; Milner J.D.; Lewis N.E.; Chang J.; Kastner D.L.; Torok K.; Oda H.; Putnam C.D.; Broderick L.;
N. Engl. J. Med. 388:2241-2252(2023)
Cited for: INVOLVEMENT IN DPMC; VARIANTS DPMC TYR-623; VAL-635 AND ASP-650; CHARACTERIZATION OF VARIANTS DPMC TYR-623; VAL-635 AND ASP-650; MUTAGENESIS OF TYR-693; FUNCTION; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.